Modulation of TNF-α expression in bone marrow macrophages: Involvement of vitamin D response element

Journal of Cellular Biochemistry

Volumn 88, Issue 5, 2003, Pages 986-998

  Hakim, Imad ^a   Bar Shavit, Zvi ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

1,25(OH)2D3; CD14; Lipopolysaccharide; Retinoic acid; RXR; VDR

Indexed keywords

ALITRETINOIN; CALCITRIOL; CD14 ANTIGEN; RETINOIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA RESPONSIVE ELEMENT; DOSE TIME EFFECT RELATION; ELECTROPHORETIC MOBILITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD14; BONE MARROW; CALCITRIOL; DRUG SYNERGISM; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D RESPONSE ELEMENT;

EID: 0037377096     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10453     Document Type: Article

References (76)

1. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T. 1981. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990-4994.
2. Abu-Amer Y, Bar-Shavit Z. 1993. Impaired bone marrow-derived macrophages differentiation in vitamin D deficiency. Cell Immunol 151:356-368.
3. Abu-Amer Y, Bar-Shavit Z. 1994, Regulation of TNF-α release from bone marrow-derived macrophages by vitamin D. J Cell Biochem 55:435-444.
4. Amento EP, Bhalla AK, Kurnick JT. 1984. 1,25(OH)2D3 induces maturation of the human monocyte cell line U937 and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest 73:731-739.
5. Anderson P. 2000. Post-transcriptional regulation of tumour necrosis factor alpha production. Ann Rheum Dis 59(Suppl):i3-i5.
6. Antras J, Lasnier F, Pairault J. 1991. Adipsin gene expression in 3T3-F442A adipocytes is post-transcriptionally down regulated by retinoic acid. J Biol Chem 266: 1157-1161.
7. Bar-Shavit Z, Noff D, Edelstein S, Meyer M, shibboleth S, Goldman R. 1981. 1,-25dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int 33: 673-676.
8. Bar-Shavit Z, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J, Kahn AJ. 1983. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 80:5907-5911.
9. Beutler BA. 1999. The role of tumor necrosis factor in health and disease. J Rheumatol 26:16-21.
10. Bhalla AK, Amento EP, Krane SM. 1986. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 98:311-322.
11. Biragyn A, Nedospasov SA. 1995. Lipopolysaccharideinduced expression of TNF-alpha gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. J Immunol 155:674-683.
12. Breen EC, van Wijnen AJ, Lian JB, Stein GS, Stein JL. 1994. In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D dependent transcriptional upregulation in intact cells. Proc Natl Acad Sci USA 91:12902-12906.
13. Carlberg C. 1993. RXR-independent action of the receptors for thyroid hormone, retinoid acid and vitamin D on inverted palindromes. Biochem Biophys Res Commun 195: 1345-1353.
14. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W. 1993. Two nuclear signaling pathways for vitamin D. Nature 361:657-660.
15. Chomczynski P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples. Biotechniques 15:532-536.
16. Cohen ML, Douvdevani A, Chaimovitz C, Shany S. 2001. Regulation of TNF-alpha by 1 alpha, 25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int 59:69-75.
17. Crawford EK, Ensor JE, Kalvakolanu I, Hasday JD. 1997. The role of 3'poly (A) tail metabolism in tumor necrosis factor-alpha regulation. J Biol Chem 272:21120-21127.
18. DeLuca HF. 1988. The vitamin D story: A collaborative of basic science and clinical medicine. FASEB J 2:224-236.
19. DeLuca HF, Cantorna MT. 2001. Vitamin D: Its role and uses in immunology. FASEB J 15:2579-25785.
20. Delude RL, Savedra RJ, Zhao H, Thieringer R, Yamamoto S, Fenton MJ, Golenbock DT. 1995. CD14 enhances cellular response to endotoxin without imparing ligandspecifi recognition. Proc Natl Acad Sci USA 92:9288-9292.
21. Evans RM. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
22. Fagan DL, Prehn JL, Adams JS, Jordan SC. 1991. The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: Marked enhancement of lipopolysaccharidestimulated interleukine-1 beta RNA levels by 1,25-dihydroxyvitamin D3. Mol Endocrinol 5:179-186.
23. Fenton MJ, Golenbock DT. 1998. LPS-binding proteins and receptors. J Leukoc Biol 64:25-32.
24. Fiers W. 1991. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285: 199-212.
25. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH. 1992. Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol 6:429-442.
26. Gavison R, Bar-Shavit Z. 1989. Impaired macrophage activation in vitamin D3 deficiency: Differential in vitro effect of 1,25-dihydroxyvitamin D3 on mouse peritoneal macrophage functions. J Immunol 143:3686-3690.
27. Gellersen B, Kempf R, Hartung S, Bonhoff A, DiMattia GE. 1992. Posttranscriptional regulation of the human prolactin gene in IM-9-P3 cells by retinoic acid. Endocrinology 131:1017-1025.
28. Giovannini L, Panichi V, Migliori M, De Pietro S, Bertelli AA, Fulgenzi A, Filippi C, Sarnico I, Taccola D, Palla R, Bertelli A. 2001. 1,25-dihydroxyvitamin D3 dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium. Transplant Proc 33:2366-2368.
29. Han J, Beutler B. 1990. The essential role of the UA-rich sequence endotoxin induced cachectin/TNF synthesis. Eur Cytokine Net 1:71-75.
30. Han J, Brown T, Beutler B. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171:465-475.
31. Haussler MR, Mangelsdorf DJ, Komm BS, Terpening CM, Yamaoka K, Allegretto EA, Baker AR, Shine J, McDonnell DP, Hughes M. 1988. Molecular biology of the vitamin D hormone. Recent Prog Horm Res 44:263-305.
32. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4: 407-414.
33. Iraqi F, Teale A. 1997. Cloning and sequencing of the tnfa genes of three inbreed mouse strains. Immunogenetics 45:459-461.
34. Jimenez-Lara AM, Aranda A. 2000. Interaction of vitamin D and retinoid receptors on regulation of gene expression. Horm Res 54:301-305.
35. Kankova M, Luini W, Pedrazzoni M, Riganti F, Sironi M, Bottazzi B, Mantovani A, Vecchi A. 1991. Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 73:466-471.
36. Kilbourn RG, Griffith OW, Gross SS. 1993. Pathogenetic mechanisms of septic shock. N Engl J Med 329:1427-1428.
37. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. 1998. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188:2091-2097.
38. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM. 1992. Retinoid X reeptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-449.
39. Kopp E, Medzhitov R, Carothers J, Xiao C, Douglas I, Janeway CA, Ghosh S. 1999. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev 13:2059-20571.
40. Kumar R, Wiebon E, Beecher SJ. 1989. The molecular clonning of the complementary deoxyribonucleic acid for bovine vitamin D-dependent calcium-binding protein: Structure of the full-length protein and evidence for homologies with other calcium-binding proteins of the troponin-C superfamily of proteins. Mol Endocrinol 3: 427-432.
41. Leid M, Kastner P, Lyons R, Nakshatri H, Sauders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, Chambon P. 1992. Purification, clonning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395.
42. Li YP, Stashenko P. 1992. Proinflammatory cytokines tumor necrosis factor-alpha and IL-6, but not IL-1, down regulate the osteocalcin gene promoter. J Immunol 148: 788-794.
43. MacGregor TM, Copeland NG, Jenkins NA, Giguere V. 1992. The murine gene for cellular retinoic acid-binding protein type II. J Biol Chem 267:7777-7783.
44. Manolagas SC, Provvedini DM, Tsoukas CD. 1985. Interaction of 1,25dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 43:113-122.
45. Markose ER, Stein JL, Stein GS, Lian JB. 1990. Vitamin D- mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci USA 87:1701-1705.
46. Minghetti PP, Norman AW. 1988. 1,25(OH)2D3 receptors: Regulation and genetic circuitry. FASEB J 2:3043-3053.
47. Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC, Collins ED, Taoka T, Sergeev I, Farach-Carsn MC. 1992. 1,25(OH)2-vitamin D3 a steroid hormone that produces biological effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41:231-240.
48. O'Malley B. 1990. The steroid receptor superfamily: More excitement predicted for the future. Mol Endocrinol 4: 363-369.
49. Old LJ. 1985. Tumor necrosis factor (TNF). Science 230: 630-632.
50. Panichi V, De Pietro S, Andreini B, Bianchi AM, Migliori M, Taccola D, Giovannini L, Tetta C, Palla R. 1998. Calcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium. Kidney Int 54:1463-1469.
51. Pike JW. 1991. Vitamin D3 receptors: Structure and function in transcription. Annual Rev Nutr 11:189-216.
52. Prehrn JL, Fagan DL, Jordan SC, Adams JS. 1992. Potentiation of lipopolysaccharide-induced tomur necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3. Blood 80:2811-2816.
53. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1983. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181-1183.
54. Prufer K, Barsony J. 2002. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol Endocrinol 16:1738-1751.
55. Raabe T, Bukrinsky M, Currie RA. 1998. Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem 273:974-980.
56. Riancho JA, Zarrabeitia MT, de Francisco AL, Amado JA, Napal J, Arias M, Gonzalez MJ. 1993. Vitamin D theraby modulates cytokine secretion in patients with renal failure. Nephron 65:364-368.
57. Rietschel ET, Brade H. 1992. Bacterial endotxins. Sci Am 267:54-61.
58. Rigby WFC. 1988. The immunobiology of vitamin D. Immunol Today 9:54-58.
59. Schrader M, Muller KM, Carlberg C. 1994. Specificity and flexibility of vitamin D signalling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 269:5501-5504.
60. Schrader M, Nayeri S, Kahlen JP, Muller KM, Carlberg C. 1995. Natural vitamin D3 response elements formed by inverted palindromes: Polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol Cell Biol 15:1154-1161.
61. Semon D, Kawashima E, Jongeneel CV, Shaklov AN, Nedospasov SA. 1987. Nucleotides sequence of the murine TNF locus, including the TNF-alpha (tumor necrosis factor) and TNF-beta (lymphotoxin) genes. Nucleic Acids Res 15:9083-9084.
62. Shany S, Levy Y, Lahav-Cohen M. 2001. The effects of 1 alpha, 24(S)-dihydroxyvitamin D2 analog on cancer cell proliferation and cytokine expression. Steroids 66:319-325.
63. Silver G, Krauter KS. 1990. Aryl hydrocarbon induction of rat cytochrome P-450d results from increased precursor RNA processing. Mol Cell Biol 10:6765-6768.
64. Staal A, van Wijnen AJ, Birkenhager JC, Pols HAP, Prahl J, Deluca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JPTM, Stein JL. 1996. Distinct conformations of vitamin D receptor/retinoid X receptor-α heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol 10:1444-1456.
65. Takashi I, Tatsushi M, Takeshige K. 2000. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide stimulated macrophages. FEBS Lett 467:160-164.
66. Takeuchi O, Akira S. 2001. Toll-like receptors: Their physiological role and signal transduction system. Int Immunol 1:625-635.
67. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS. 2000. Toll-like receptor 4, but not toll-like receptor 2, is a signalling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 165:5780-5787.
68. Tokuda N, Mizuki N, Kasahara M, Levy RB. 1992. 1,25- Dihydroxyvitamin D3 downregulation of HLA-DR on human peripheral blood monocytes. Immunology 75: 349-354.
69. Tsan MF, Clark RN, Goyert SM, White JE. 2001. Induction of TNF-alpha and MnSOD by endotoxin: Role of membrane CD14 and Toll-like receptor-4. Am J Physiol Cell Physiol 280:C1422-C1430.
70. Tsonis PA, Sargent MT, Del Rio-Tsonis K, Chang Jung J. 1996. 9-cis-retinoic acid antaginezes the stimulatory effect of 1,25-dihydroxyvitamin D3 on chondrogenesis of chick limb bud mesenchymal cells: Interactions of their receptors. Int J Dev Biol 40:1053-1059.
71. Ulevitch RJ, Tobias PS. 1995. Receptor-deppendent mechanism of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13:437-457.
72. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14: A receptor for complexes of lipopolysaccharide (LPS) and binding protein. Science 249:1431-1433.
73. Wu Y, Craig TA, Lutz WH, Kumar R. 1999. Identification of 1 alpha, 25-dihydroxyvitamin D3 response elements in the human transforming growth factor-beta 2 gene. Biochemistry 38:2654-2660.
74. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 17:284-288.
75. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG. 1991. RXR beta: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251-1266.
76. Zou A, Elgort MG, Allegretto EA. 1997. Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promotor via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. J Biol Chem 272:19027-19034.